Accounts receivable, net of allowance for expected credit losses (3,842 and 4,649, respectively)
143,675
131,318
142,269
142,181
Inventories
79,082
78,510
82,458
74,956
Short-term restricted cash
2,414
2,410
2,393
2,359
Refundable income taxes
5,846
6,838
7,888
9,728
Prepaid expenses and other current assets
53,150
50,214
60,549
64,660
Current assets held for sale
71,387
77,178
74,689
73,535
Total current assets
681,351
726,985
779,902
708,339
Property, plant and equipment, net
172,427
171,832
152,032
153,954
Long-term marketable securities
196,087
177,831
155,914
201,585
Long-term deferred tax assets
494
501
527
726
Operating lease right-of-use assets
61,421
59,451
57,752
54,048
Goodwill
547,457
553,070
702,559
702,395
Intangible assets, net
85,688
91,433
96,604
101,814
Long-term income taxes receivable
45,600
45,600
45,600
45,600
Other assets
8,997
8,814
7,743
6,115
Noncurrent assets held for sale
76,689
68,372
75,802
85,006
Total assets
1,876,211
1,903,889
2,074,435
2,059,582
Accounts payable
39,381
33,136
38,767
37,722
Deferred revenue
36,041
39,013
32,861
31,569
Derivative liability
28,435
29,615
33,304
33,420
Accrued warranty and retrofit costs
4,047
4,157
4,315
4,713
Accrued compensation and benefits
30,965
29,146
30,440
35,799
Customer deposits
35,355
36,217
36,885
26,499
Accrued income taxes payable
6,775
8,753
11,864
9,416
Deposit received for the sale of b medical systems business
28,000
-
-
-
Accrued expenses and other current liabilities
34,249
45,739
44,007
30,268
Current liabilities held for sale
29,326
31,416
34,770
28,268
Total current liabilities
272,574
257,192
267,213
237,674
Long-term deferred tax liabilities
15,836
15,747
15,248
18,245
Long-term operating lease liabilities
53,967
55,711
54,462
51,244
Other long-term liabilities
10,725
10,892
11,475
11,142
Noncurrent liabilities held for sale
12,980
9,670
11,205
14,291
Total liabilities
366,082
349,212
359,603
332,596
Common stock, 0.01 par value - 125,000,000 shares authorized, 57,226,616 shares issued and 43,764,747 shares outstanding at june 30, 2026 59,320,848 shares issued and 45,858,979 shares outstanding at september 30, 2025
572
596
595
594
Additional paid-in capital
493,071
538,782
531,245
529,605
Accumulated other comprehensive loss
-28,740
-27,471
-20,576
-22,213
Treasury stock, at cost - 13,461,869 shares at june 30, 2026 and september 30, 2025
200,956
200,956
200,956
200,956
Retained earnings
1,246,182
1,243,726
1,404,524
1,419,956
Total stockholders' equity
1,510,129
1,554,677
1,714,832
1,726,986
Total liabilities and stockholders' equity
1,876,211
1,903,889
2,074,435
2,059,582
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.